Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

Published Date: 29 Dec 2023

Method might enable a reduction of CHOP that is responsive.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

2.

Young adults who are obese are at risk for 17 different types of cancer in the future.

3.

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

4.

For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

5.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot